Kelyniam Global, Inc. (KLYG)
USD 0.22
(22.22%)
USD 0.22
(22.22%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -239.16 Thousand USD | -339.4% |
| 2022 | -54.43 Thousand USD | -125.68% |
| 2021 | 211.99 Thousand USD | 171.16% |
| 2020 | 78.18 Thousand USD | 175.66% |
| 2019 | -103.33 Thousand USD | -1263.19% |
| 2018 | -7580.00 USD | -107.05% |
| 2017 | 107.45 Thousand USD | 891.24% |
| 2016 | -13.58 Thousand USD | 73.26% |
| 2015 | -50.78 Thousand USD | -354.31% |
| 2014 | 19.96 Thousand USD | 127.02% |
| 2013 | -73.9 Thousand USD | 0.0% |
| 2007 | 173.08 Thousand USD | 118.79% |
| 2006 | 79.1 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 134.73 Thousand USD | 37.19% |
| 2024 Q2 | 37.81 Thousand USD | -71.94% |
| 2023 Q1 | -106.12 Thousand USD | -632.87% |
| 2023 FY | -281.16 Thousand USD | -416.55% |
| 2023 Q2 | -151.36 Thousand USD | -42.63% |
| 2023 Q3 | -121.9 Thousand USD | 19.46% |
| 2023 Q4 | 98.21 Thousand USD | 180.57% |
| 2022 Q4 | -14.48 Thousand USD | -174.64% |
| 2022 Q2 | -60.3 Thousand USD | -6447.37% |
| 2022 Q1 | 950.00 USD | -98.18% |
| 2022 FY | -54.43 Thousand USD | -125.68% |
| 2022 Q3 | 19.4 Thousand USD | 132.17% |
| 2021 FY | 211.99 Thousand USD | 171.16% |
| 2021 Q2 | 44.73 Thousand USD | 142.44% |
| 2021 Q3 | 96.73 Thousand USD | 116.25% |
| 2021 Q1 | 18.45 Thousand USD | 124.49% |
| 2021 Q4 | 52.09 Thousand USD | -46.15% |
| 2020 Q1 | 86.55 Thousand USD | -34.99% |
| 2020 Q4 | -75.33 Thousand USD | -243.56% |
| 2020 FY | 78.18 Thousand USD | 175.66% |
| 2020 Q3 | 52.47 Thousand USD | 262.37% |
| 2020 Q2 | 14.48 Thousand USD | -83.27% |
| 2019 Q2 | -173.23 Thousand USD | -30398.94% |
| 2019 FY | -103.33 Thousand USD | -1263.19% |
| 2019 Q4 | 133.14 Thousand USD | 348.54% |
| 2019 Q1 | -568.00 USD | 0.0% |
| 2019 Q3 | -53.57 Thousand USD | 69.08% |
| 2018 FY | -7580.00 USD | -107.05% |
| 2017 FY | 107.45 Thousand USD | 891.24% |
| 2016 FY | -13.58 Thousand USD | 73.26% |
| 2015 FY | -50.78 Thousand USD | -354.31% |
| 2014 Q1 | 51.05 Thousand USD | 0.0% |
| 2014 FY | 19.96 Thousand USD | 127.02% |
| 2014 Q3 | 72.3 Thousand USD | 0.0% |
| 2014 Q4 | -115.83 Thousand USD | -260.21% |
| 2013 Q2 | 7295.00 USD | 142.22% |
| 2013 Q1 | -17.27 Thousand USD | 0.0% |
| 2013 FY | -73.9 Thousand USD | 0.0% |
| 2008 Q1 | 57.95 Thousand USD | -53.65% |
| 2007 Q1 | 5219.00 USD | 0.0% |
| 2007 Q4 | 125.03 Thousand USD | 1314.25% |
| 2007 Q3 | 8841.00 USD | -84.15% |
| 2007 FY | 173.08 Thousand USD | 118.79% |
| 2007 Q2 | 55.79 Thousand USD | 969.06% |
| 2006 FY | 79.1 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 12.805% |
| IR-Med Inc. | -4.91 Million USD | 95.13% |
| Polarean Imaging plc | -12.55 Million USD | 98.095% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 154.582% |
| Avitar, Inc. | 2.73 Million USD | 108.752% |
| AVITA Medical, Inc. | -40.4 Million USD | 99.408% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | 65.979% |
| Össur hf. | 87.46 Million USD | 100.273% |
| Zecotek Photonics Inc. | -3.65 Million USD | 93.46% |
| QHSLab, Inc. | -240.15 Thousand USD | 0.413% |
| Wellstar International, Inc. | -1.79 Million USD | 86.674% |
| Össur hf. | 87.46 Million USD | 100.273% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 111.493% |
| Escalon Medical Corp. | -104.47 Thousand USD | -128.92% |
| Aurora Spine Corporation | -446.19 Thousand USD | 46.399% |
| BrainsWay Ltd. | -4.92 Million USD | 95.146% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.45 Million USD | 97.472% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 186.032% |
| Vivos Inc. | -2.79 Million USD | 91.437% |
| MicroPort Scientific Corporation | -516.16 Million USD | 99.954% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 86.5% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 36.88% |
| Nanomix Corporation | -8.43 Million USD | 97.165% |
| Theraclion SA | -3.48 Million USD | 93.129% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | 66.173% |
| Positron Corporation | -1.36 Million USD | 82.424% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | 88.418% |
| Lombard Medical, Inc. | -29.33 Million USD | 99.185% |
| ALR Technologies Inc. | -2.94 Million USD | 91.883% |
| Stratec SE | 25.26 Million USD | 100.947% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 695.074% |
| Heart Tronics, Inc. | 14.46 Million USD | 101.654% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | -98.435% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 98.846% |
| SANUWAVE Health, Inc. | -540 Thousand USD | 55.71% |
| VMS Rehab Systems, Inc. | -68.66 USD | -348233.819% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 93.082% |
| Ingen Technologies, Inc. | -1.61 Million USD | 85.179% |
| Odyssey Group International, Inc. | 14.26 Million USD | 101.677% |
| United American Healthcare Corporation | -67 Thousand USD | -256.964% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | 41.306% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | 62.318% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | 60.24% |
| Urologix, Inc. | -6.93 Million USD | 96.549% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | 81.069% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 96.182% |
| SS Innovations International, Inc. | -20.66 Million USD | 98.843% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | -3.876% |
| Smith & Nephew plc | 425 Million USD | 100.056% |
| NIOX Group Plc | 4.6 Million USD | 105.199% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 162.312% |
| Broncus Holding Corporation | -33.22 Million USD | 99.28% |
| Brain Scientific Inc. | -9.6 Million USD | 97.511% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 97.483% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | -294.02% |